Save information for later
Sign Up

Learn About Spinocerebellar Ataxia Type 4

What is the definition of Spinocerebellar Ataxia Type 4?
Spinocerebellar ataxia 4 (SCA4) is a very rare form of hereditary progressive movement disorder. Symptoms include muscle weakness (atrophy) and difficulty coordinating body movements (ataxia), most notably causing a jerky, unsteady walking style (gait) and difficulty speaking (dysarthria). A distinctive feature of SCA4 is the progressive loss of feeling or sensation in the hands and feet (peripheral neuropathy) and loss of reflexes. SCA4 is inherited in an autosomal dominant manner. Although SCA4 has been linked to a location on chromosome 16, (16q22.1), the gene which causes SCA4 when mutated has not been found. Diagnosis is based on symptoms consistent with the disease.
What are the alternative names for Spinocerebellar Ataxia Type 4?
  • Spinocerebellar ataxia 4
  • SCA4
  • Spinocerebellar ataxia autosomal dominant with sensory axonal neuropathy
  • Spinocerebellar ataxia type 4
Who are the top Spinocerebellar Ataxia Type 4 Local Doctors?
Distinguished in Spinocerebellar Ataxia Type 4
Neurology
Distinguished in Spinocerebellar Ataxia Type 4
Neurology

Northwestern Medical Faculty Foundation

675 N Saint Clair St, 
Chicago, IL 
 (23.7 mi)
Experience:
26+ years
Languages Spoken:
English

Puneet Opal is a Neurologist in Chicago, Illinois. Dr. Opal has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. His top areas of expertise are Spinocerebellar Ataxia Type 1, Giant Axonal Neuropathy, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.

Advanced in Spinocerebellar Ataxia Type 4
Internal Medicine
Advanced in Spinocerebellar Ataxia Type 4
Internal Medicine

Select Rehabilitation LLC

2600 Compass Rd, 
Glenview, IL 
 (18.3 mi)
Experience:
44+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Thomas Vaughan is an Internal Medicine provider in Glenview, Illinois. Dr. Vaughan has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. His top areas of expertise are High Cholesterol, Sitosterolemia, Periventricular Heterotopia, and Cortical Dysplasia. Dr. Vaughan is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Spinocerebellar Ataxia Type 4
Geriatrics | Internal Medicine
Experienced in Spinocerebellar Ataxia Type 4
Geriatrics | Internal Medicine

Advocate Medical Group Primary Care - Ballard Road

1775 Ballard Road, 
Park Ridge, IL 
 (14.7 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Brian Rubenstein is a Geriatrics specialist and an Internal Medicine provider in Park Ridge, Illinois. Dr. Rubenstein and is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. His top areas of expertise are Memory Loss, Spinocerebellar Ataxia Type 5, Spinocerebellar Ataxia Type 12, and Spinocerebellar Ataxia Type 2. Dr. Rubenstein is currently accepting new patients.

What are the latest Spinocerebellar Ataxia Type 4 Clinical Trials?
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)

Background: Spinocerebellar ataxia type 7 (SCA7) is a disease in which people have problems with coordination, balance, speech and vision. It is caused by a change in the ATXN7 gene. A mutation in this ATXN7 gene causes changes in eye cells, which can lead to vision loss. There is no cure for SCA7 but researchers are looking for possible treatments. Researchers need more information about SCA7. They want to c...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center